PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22542401-7	2012	We demonstrate that the AFBN pre-treatment protocol for CSF significantly enhances the measurement of glutamine synthetase (GS) and myelin basic protein (MBP) in CSF but does not affect detection of glial fibrillary protein (GFAP), amyloid beta 42 (Abeta42), total tau (t-tau) or phosphorylated tau (p-tau).	afbn	24-28	microtubule associated protein tau	Homo sapiens	265-268	
22542401-7	2012	We demonstrate that the AFBN pre-treatment protocol for CSF significantly enhances the measurement of glutamine synthetase (GS) and myelin basic protein (MBP) in CSF but does not affect detection of glial fibrillary protein (GFAP), amyloid beta 42 (Abeta42), total tau (t-tau) or phosphorylated tau (p-tau).	afbn	24-28	microtubule associated protein tau	Homo sapiens	272-275	
22542401-7	2012	We demonstrate that the AFBN pre-treatment protocol for CSF significantly enhances the measurement of glutamine synthetase (GS) and myelin basic protein (MBP) in CSF but does not affect detection of glial fibrillary protein (GFAP), amyloid beta 42 (Abeta42), total tau (t-tau) or phosphorylated tau (p-tau).	afbn	24-28	microtubule associated protein tau	Homo sapiens	272-275	
22542401-7	2012	We demonstrate that the AFBN pre-treatment protocol for CSF significantly enhances the measurement of glutamine synthetase (GS) and myelin basic protein (MBP) in CSF but does not affect detection of glial fibrillary protein (GFAP), amyloid beta 42 (Abeta42), total tau (t-tau) or phosphorylated tau (p-tau).	afbn	24-28	microtubule associated protein tau	Homo sapiens	272-275